Neobiomics is dedicated to solving the unmet needs in neonatology, addressing major challenges for preterm infants. Neobiomics is a fast-growing company headquartered at the Karolinska Institute Science Park in Stockholm, Sweden. Since our start we have distributed our first product to over 200 neonatal intensive care units in Europe. As of today, Neobiomics has two products available on the market. ProPrems®, a high-quality and well-documented probiotic blend and NeoMega36®, a tailor-made oil enriched with arachidonic acid and DHA, to support the development of normal vision function in preterm infants. Founded by a researcher and practicing neonatologist, we have a strong clinical and academic network in Europe and beyond.
| Website | https://neobiomics.eu |
| Employees | 16 (10 on RocketReach) |
| Founded | 2016 |
| Address | Fogdevreten 2A, Solna, Stockholm County 171 65, SE |
| Technologies |
JavaScript
,
HTML
,
PHP
+18 more
(view full list)
|
| Industry | Hospitals and Health Care |
| Keywords | Scientific Research, Gut Microbiome, Biotechnology, Microbiome Analysis, Health Technology, Precision Medicine, Nutritional Science, Human Health, Personalized Nutrition, Clinical Trials, Health Supplements, Data Analysis, Scientific Innovation, Omega 3 Fatty Acids, Digital Health, Probiotics, Health Innovation, Personalized Healthcare, Functional Foods, Pharmaceutical Research |
| Competitors | Roche, Thermo Fisher Scientific, Lonza, MilliporeSigma, QIAGEN, Promega Corporation, New England Biolabs, Takara Bio USA, Inc., Bioneer, InvivoGen +41 more (view full list) |
Looking for a particular Neobiomics employee's phone or email?
Emma Höglund is the CEO of Neobiomics.
10 people are employed at Neobiomics.
Neobiomics is based in Solna, Stockholm County.